Topic

All

8
Dec
2021

Three Core Questions Underlying Durable Behavior Change

Each of us would be happier and healthier if we could adopt and maintain healthier behaviors. Many of us – including providers, organizational heads, community leaders, parents – hope to cultivate healthier behavior in others.    The difficulty we experience attaining these common goals reflects three underlying questions around behavior change. Is the most effective locus of intervention the individual...
Read More
6
Dec
2021

Targeted Small Molecule Protein Degraders: Nello Mainolfi on The Long Run

Today’s guest on The Long Run is Nello Mainolfi. Nello is the president and CEO of Cambridge, Mass.-based Kymera Therapeutics. Kymera is working on targeted protein degraders. These are orally available small molecule compounds. Many in biopharma are excited about them because they have a clever design that allows them to go after targets that have previously been out of...
Read More
5
Dec
2021

Corporate Health and Wellness Has New Urgency And Vision

Like no other event in our collective experience, the pandemic reminded us of the need for an integrative view of wellbeing beyond traditional measures of physical health. Focusing exclusively on cholesterol level and bone density, for example, would be hopelessly inadequate for the needs of today.  I continued to be haunted by Zak Kohane’s description of the many children’s hospitals...
Read More
2
Dec
2021

The Variant on the Move

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.   Subscribe Now   Sign in to your account.
29
Nov
2021

Obesity Is Rising; Can Health Coaches & Tech Drive Durable Behavior Change?

As we enter the holiday eating season – quickly followed by the New Year get-in-shape resolution season – let’s look at obesity challenge head-on.  Expert physicians who study obesity recognize the condition as a complex disease associated with profound health consequences. It also represents, for many health tech entrepreneurs, a high-value problem to be solved. Obesity has been ratcheting upward...
Read More
22
Nov
2021

Reviving Targeted Radiopharmaceuticals for Cancer: Ken Song on The Long Run

Today’s guest on The Long Run is Ken Song. Ken is the CEO of San Diego-based RayzeBio. At RayzeBio, Ken discovered new opportunity in an area cancer R&D that had been long ago abandoned. It’s about creating targeted cancer therapies loaded with radioactive isotopes to give them extra tumor-killing punch. These aren’t the same thing as antibody-drug conjugates, in which...
Read More
18
Nov
2021

Precision Health’s Next Great Challenge: Behavior Change

Humility may not be the first word you associate with “genetics,” “precision medicine,” and “Harvard,” but it was unquestionably the theme of the day at a fascinating panel this week convened by the Harvard Data Science Initiative. The discussion (video here), was remarkably grounded. It reflected hard-earned learnings from experts who have tried to implement data-driven, “precision” health solutions outside the...
Read More
16
Nov
2021

A Trek in the Himalayas for Cancer Research

The biotech community can do extraordinary things when fixated on a goal. Like curing cancer. I’m excited to announce today that I’m taking a team of biotech leaders on a mission to raise $1 million for cancer research at Fred Hutch. This group will come together on a trek to Everest Base Camp. It’s a legendary hike in the Himalayas...
Read More
15
Nov
2021

Motivating a Modicum of Exercise: The Healthtech Opportunity

“It’s been a busy few weeks for product announcements in the world of fitness,” industry observer Anthony Vennare recently commented, citing the latest offerings from the Peloton, Mirror, Tempo, and other digital fitness platforms. On the one hand, these developments are encouraging, offering customers pursuing fitness — and who are willing and able to afford the steep premiums — a...
Read More
8
Nov
2021

A Remarkable Life in Science: David Baltimore on The Long Run

Today’s guest on The Long Run is David Baltimore. David is one of the most accomplished biomedical scientists – and scientific citizens — of the past 50 years. He recently won Lasker~Koshland Award for Special Achievement. The award was granted “for the breadth and beauty of his discoveries in virology, immunology, and cancer; for his academic leadership; for his mentorship...
Read More